Search clinical trials for: Optimized Extinction

Total 536 results

ANRS, Emerging Infectious Diseases
Roche Pharma AG

Completed

ANRS HC20 Effectiveness of an Optimized Anti HCV PegIFN-alpha2a + Ribavirin on Sustained Virological Response in Patients With HCV Genotype 1 and 4 Non Responders and Co-infected With HIV (ETOC)

Hepatitis

France
Peking Union Medical College Hospital
Xuanwu Hospital, Beijing; Beijing Tongren Hospital

Unknown

Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part II) (DCLI-II) (DCLI-II)

Vascular Diseases | Diabetes

China
Peking Union Medical College Hospital
Xuanwu Hospital, Beijing; Beijing Tongren Hospital

Unknown

Optimized Strategy for Diabetic Patients With Critical Limb Ischemia(Part I) (DCLI-I)

Vascular Diseases | Diabetes

China
Assistance Publique - Hôpitaux de Paris

Completed

Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic Strategy (DREPANOX)

Sickle Cell Anemia

France
Red Cross Hospital Beverwijk

Unknown

Prophylaxis of Thromboembolic Complications Trial: Thromboprophylaxis Needed in Below Knee Plaster Cast Immobilization for Ankle and Foot Fractures (PROTECT)

Deep Vein Thrombosis | Pulmonary Embolism

Netherlands
Changhai Hospital

Completed

Optimization of Antiviral Therapy of Chronic HBV Infection

Hepatitis B | Adverse Effects | Australia Antigen Positive

China
Innovative Medical

Completed

An Evaluation of Outcomes Following Wavefront Optimized or Wavefront Guided Lasik Procedure in Low to Moderate Myopic Patients

Myopia

United States
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (MOTIVATE 2)

HIV Infections

Netherlands, United States, Italy, Spain, United Kingdom, France, Germany, Australia, Switzerland, Belgium, Canada, Poland, Sweden
Kennemer Gasthuis
Medtronic

Unknown

Optimized Heart Failure Therapy Through Continuous Monitoring (pharao)

Heart Failure

Netherlands
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of HIV-1 Infected Subjects (MOTIVATE 1)

HIV Infections

United States, Canada
Galderma Brasil Ltda.

Completed

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

Dermatitis, Atopic

Brazil
Uniformed Services University of the Health Sciences
United States Department of Defense; US Department of Veterans Affairs; Walter...

Unknown

Delivery of Self Training and Education for Stressful Situations-Telephone Version (DESTRESS-T)

PTSD

United States
Henry M. Jackson Foundation for the Advancement...
National Institute of Mental Health (NIMH); United States Department of Defense

Completed

DElivery of Self Training and Education for Stressful Situations-Primary Care Version (DESTRESS-PC)

Posttraumatic Stress Disorder (PTSD)

United States
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

HIV Infections

France
Central Institute of Mental Health, Mannheim
German Research Foundation

Unknown

The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes (SFB636D6)

Alcohol Drinking

Germany
University of Patras

Completed

Optimized Perioperative Analgesia Reduces the Prevalence and the Intensity of Phantom Pain in Lower Limb Amputation

Phantom Limb Pain

Greece
Hoffmann-La Roche
Trimeris

Terminated

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients (AMICI)

HIV Infections

United States, Puerto Rico
National Taiwan University Hospital
Far Eastern Memorial Hospital

Completed

Outcome Predictors in Patients With Severe Sepsis and Optimized Central Venous Oxygen Saturation

Sepsis

Taiwan
Tibotec Pharmaceuticals, Ireland

Completed

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

HIV
Doroana, Maria Manuela, M.D.
Merck Sharp & Dohme LLC; Eurotrials Brasil Consultores Cientificos Ltda

Completed

Raltegravir With Optimized Background Therapy (OBT) in Multiple Experienced HIV-infected Patients

HIV Infections
Shanghai Mental Health Center

Unknown

Effect Study of Optimized Intervention to Heroin Addicts

Heroin Dependence

China
University of Milan
IRCCS Azienda Ospedaliero-Universitaria di Bologna; Valduce Hospital; Ente Ospedaliero... and other collaborators

Completed

Optimization of Ventilator Setting for Acute Exacerbations of Chronic Obstructive Pulmonary Disease (NIMV01AECB)

Acute Exacerbation of Chronic Obstructive Airways Disease

Italy, Switzerland
ViiV Healthcare
Pfizer

Completed

Trial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected Subjects

HIV Infections

Canada, United States, United Kingdom, Netherlands, Australia, Germany, Spain, Belgium, Switzerland
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC; Janssen-Cilag Tibotec

Completed

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses (ANRS139 TRIO)

HIV Infections

France
Stiftung Institut fuer Herzinfarktforschung
GlaxoSmithKline; University Hospital Muenster; Klinikum Nürnberg

Completed

OPTAMI (Optimized Therapy of Acute Myocardial Infarction) - Registry (OPTAMI)

Myocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial Infarction

Germany
Novartis

Completed

An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

Liver Transplantation
University Hospital, Bordeaux

Completed

Optimisation of Monitoring for Clinical Research Studies (OPTIMON)

Healthy

France
Myrexis Inc.

Terminated

A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy

HIV Infections

Canada, United States
Copenhagen University Hospital at Herlev
Odense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaborators

Completed

Peptic Ulcer Perforation Study (PULP)

Peptic Ulcer Perforation

Denmark
Arcispedale Santa Maria Nuova-IRCCS
Medtronic

Completed

APAF: Assessment of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation

Atrial Fibrillation | Congestive Heart Failure

Italy
Biotronik, Inc.

Completed

Interventricular Delay of Lumax HF-T for Heart Failure

Congestive Heart Failure

Switzerland, United States
Shenyang Northern Hospital

Completed

Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

Ischemic Heart Disease | Acute Coronary Syndromes

China
Vertigone Inc.

Unknown

Visual Feedback Goggle for Positional Vertigo Treatment

Vertigo | Positional Vertigo

United States
National Institute of Allergy and Infectious Diseases...

Completed

HIV-1 Vaccine Test in Uninfected Adult Volunteers

Healthy | HIV Seronegativity

United States
McGill University
Canadian Diabetes Association

Completed

Impact of Optimized Titration and Delivery of Bedtime Insulin on Prevention of Nocturnal Hypoglycemia

Type 1 Diabetes Mellitus

Canada
Tanox

Unknown

TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1

HIV Infections

United States, Puerto Rico, Canada

3

Subscribe